@FierceMedDev: ICYMI yesterday: Imaging pen may detect skin cancer faster. Article | Follow @FierceMedDev
@StacyALawrence: Med tech M&A gets much, much bigger during the first half. Special report | Follow @StacyALawrence
@VarunSaxena2: ICYMI last week: UPDATED with information from interview of CEO: NeuroPace RNS Stimulator secures add-on payments from CMS. Story | Follow @VarunSaxena2
@EmilyWFierce: Scientists created a 3-D, doughnut-shaped model of the human brain that can imitate neurological function. More from the NYT | Follow @EmilyWFierce
> Dr. Joseph Gulfo, former CEO of Mela Sciences, talks about the battle to get FDA approval for MelaFind in his new book. Review
> Researchers are exploring the use of fluorescence-based brain imaging without requiring craniotomy as an alternative to current, less efficient imaging methods. Study
> Population health and work flow technology company Acupera completed a $4 million financing led by Lightspeed Venture Partners. The funding will be used to scale the company's product development team. Release
Biotech News
@FierceBiotech: ICYMI yesterday: J&J's diabetes combo wins FDA nod in a fast-crowding space. Article | Follow @FierceBiotech
@DamianFierce: Digging into the FDA's priority review voucher. Who's willing to pay big for one? Report | Follow @DamianFierce
@EmilyMFierce: Gene editing method kills cervical cancer cells. More from FierceBiotech Research | Follow @EmilyMFierce
> Tokai pitches a $75M IPO to fund its three-in-one cancer drug. News
> Intercept leaps again as deeper NASH data quiet some fears. Story
> UniQure bets on a gene therapy for heart failure. Article
Pharma News
@FiercePharma: Tops on FP Monday: Former top Sanofi exec Whitaker nabbed by Synta to shuttle cancer drug to market. Article | Follow @FiercePharma
@EricPFierce: Boehringer Ingelheim cutting jobs in Germany in 15% cost reduction move. Article| Follow @EricPFierce
@CarlyHFierce: Generic Viagra Delivers Hidden Billionaire Duo in Brazil. Bloomberg story | Follow @CarlyHFierce
> Valeant's No. 3 shareholder: We don't need Allergan. Story
> Syria broadens corruption accusations against GlaxoSmithKline. Report
Biotech Research News
> 3-D bioengineered brain tissue grown in lab. Report
> Small molecule inhibitor reverses cognitive deficits of Alzheimer's in mice. More
> Glaxo: Ebola vaccine could be ready by 2015. Item
> Malaria vaccine alternative shows high protection in mice. Article
> Gene editing method kills cervical cancer cells. Story
Pharma Manufacturing News
> Baxter to add recombinant protein processing suite at Singapore plant. More
> Recalls overseen by FDA soar in 2013, 2014. Item
> Report: Immigrants make up 26% of U.S. drug production and distribution workforce. Story
> Pakistan indicts 76 customs officers in fake drug probe. News
> U.S. health emergency facilities ready to produce Ebola drugs. Article